Background:
Pirfenidone (PFD) is a molecule that exhibits antifibrotic properties in a variety of in vitro and animal models of lung, liver and renal fibrosis. These pathologies share many fibrogenic pathways with an abnormal fibrous wound-healing process; consequently, tissue repair and tissue regeneration-regulating mechanisms are altered.ObjectiveTo investigate the usefulness of PFD as an antifibrotic agent in clinical and experimental models of fibrotic disease.
Conclusions:
There is a growing understanding of the molecular effects of PFD on the wound healing mechanism, leading to novel approaches for the management of fibrosis in lung, liver and renal tissues. Although the optimum treatment for fibrosis remains undefined, it is possible that combined therapeutic regimens that include this wide-application molecule, pirfenidone, could offer a useful treatment for fibrotic disease.
Read the original article at Fibrogenesis and Tissue Repair.
The multifaceted role of pirfenidone and its novel targets
Most recent items in "Тъканно инженерство":
9th Oct Тъканно инженерство: TinkerCell: modular CAD tool for synthetic biology
Background:Synthetic biology brings together concepts and techniques from engineering and biology. In this field, computer-aided design (CAD) is necessary in order to bridge the gap between computational modeling and biological data. Using a CAD application, it would be possible to construct m...
9th Oct Тъканно инженерство: Development of biomaterial scaffold for nerve tissue engineering: Biomaterial mediated neural regeneration
Neural tissue repair and regeneration strategies have received a great deal of attention because it directly affects the quality of the patient's life. There are many scientific challenges to regenerate nerve while using conventional autologous nerve grafts and from the newly developed therapeutic ...
9th Oct Тъканно инженерство: Focus on collagen: in vitro systems to study fibrogenesis and antifibrosis -- state of the art
Fibrosis represents a major global disease burden, yet a potent antifibrotic compound is still not in sight. Part of the explanation for this situation is the difficulties that both academic laboratories and research and development departments in the pharmaceutical industry have been facing in re-e...
9th Oct Тъканно инженерство: The Pin 1 inhibitor juglone attenuates kidney fibrogenesis via Pin 1-independent mechanisms in the unilateral ureteral occlusion model
Background:Pin 1 is a peptidyl-prolyl isomerase inhibitor related to cyclophilin A and FK506 binding protein (FKBP). Juglone (5-hydroxy-1,4-naphthoquinone) is a natural inhibitor of Pin 1 with anti-inflammatory and antifibrotic properties. We evaluated the role of Pin 1 in renal fibrogenesis b...
9th Oct Тъканно инженерство: Procollagen type I N-terminal propeptide (PINP) is a marker for fibrogenesis in bile duct ligation-induced fibrosis in rats
Background:Fibrosis can be described as the excess deposition of extracellular matrix (ECM) components, such as collagens and proteoglycans. Fibrosis of the liver, which eventually leads to cirrhosis, is a major global health problem. Being able to measure fibrosis progression may enable timel...
Анатомия и физиология
|
|
Биохимия
|
|
Биоинформатика
|
|
Кардиология
|
|
Молекулярна и клетъчна биология
|
|
Клинични проучвания
|
|
Биология на развитието
|
|
Генетика
|
|
Хематология
|
|
Имунология
|
|
Микробиология и вирусология
|
|
Нанотехнологии
|
|
Неврология
|
|
Онкология
|
|
Патология
|
|
Фармакология
|
|
Растителни биотехнологии
|
|
Протеомика
|
|
Сигнална трансдукция
|
|
Стволови клетки
|
|
Тъканно инженерство
|
| The multifaceted role of pirfenidone and its novel targets Mesenchymal cell survival in airway and interstitial pulmonary fibrosis Achievements and challenges in bioartificial kidney development The role of renin angiotensin system inhibition in kidney repair A novel soft-tissue in vitro model for bisphosphonate-associated osteonecrosis - view all - |
|
|
2008 - 2010 LifeSciences.BG
| Some rights reserved